In Vitro Investigation of the Cytotoxic Activity of Emodin 35 Derivative on Multiple Myeloma Cell Lines

BACKGROUND: Bortezomib is used for treating multiple myeloma (MM); however, it has considerable adverse effects. Emodin has been reported to exhibit inhibitory effects on MM cell lines. We investigated the efficacy of emodin 35 (E35), an emodin derivative, using U266 and MM1s cell lines in treating...

Full description

Saved in:
Bibliographic Details
Published in:Evid Based Complement Alternat Med
Main Authors: Zheng, Jing, Chen, Yingyu, Zheng, Zhihong, Chen, Yanxin, Chai, Yujuan, Wang, Wenfeng, Asakawa, Tetsuya, Hu, Jianda
Format: Artigo
Language:Inglês
Published: Hindawi 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7850823/
https://ncbi.nlm.nih.gov/pubmed/33564319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6682787
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items